You searched for metabolic diseases - Page 37 of 64

News and Trends 28 Apr 2020

Anti-Aging Treatments at Forefront of Astellas’ €80M UK Acquisition

…mitochondrial diseases. Through the acquisition, Astellas gains access to Nanna’s drug discovery technology, which focuses on drugs that target the mitochondria, the energy-producing machinery in human cells. In addition to…

April 28, 2020 - 3 minutesmins - By David Kirk

In Depth 24 Jan 2025

Why are there only 20 cell and gene therapies in Europe?

…has historically accepted only incremental premiums on incremental innovation, and only if there is robust comparative data. Because of that, insisting on gene therapies for diseases where patients have an…

January 24, 2025 - 9 minutesmins - By Jules Adam

News and Trends 15 Oct 2020

Swiss Biotech Launches Amidst Hot Streak for Rare Autoimmune Disease

…so the medical need is high,” commented Chord Therapeutics’ CEO, Tom Plitz. “Although rare diseases affect only a small proportion of the overall population, these patients affected by rare diseases…

October 15, 2020 - 3 minutesmins - By Helen Albert

News and Trends 16 Dec 2022

Providence Therapeutics’ mRNA rabies vaccine hits milestone

…Providence’s clinically validated mRNA technology platform. “We are pleased to demonstrate that Providence’s mRNA technology supports development of additional products that fight a number of infectious diseases,” said Brad Sorenson,…

December 16, 2022 - 2 minutesmins - By Jim Cornall

Best in Biotech 30 Jun 2023

Five biotech companies making a name for themselves in Vancouver

…organ functions to treat diseases; essentially printing materials to be introduced into the human body. The Vancouver-based biotech company has its initial focus on type 1 diabetes and liver diseases….

June 30, 2023 - 6 minutesmins - By Willow Shah-Neville

Dr. Grégoire Stik, group leader at the Josep Carreras Leukaemia Research Institute and co-author of the study.

News and Trends 11 Jul 2023

Immune memory research could lead to next generation of epigenetic drugs

…memory cells, allowing for a fast activation of these cells. These features are altered in chronic inflammation diseases like asthma and could be important in autoimmune diseases and cancer. The…

July 11, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 2 May 2016

What’s the Vatican doing with Biotech? Awarding Billionaire Doctors for Cancer & Stem Cell Research

…over the weekend) looked to specifically discuss pediatric cancers, rare genetic diseases and also age-related diseases. In Pope Francis’ opening address, he highlights the concern that such diseases are a…

May 2, 2016 - 4 minutesmins - By Dani Bancroft

In Depth 17 Apr 2024

Small but mighty: The role of small-molecule drugs in disease treatment

…to treat a range of different indications. In this article, we explore the field of small-molecule drugs, including what they are, their advantages and disadvantages, and which diseases they can…

April 17, 2024 - 8 minutesmins - By Willow Shah-Neville

In Depth 22 Jul 2022

The coming of age story of RNAi technology

…levels and another for rare hematological diseases like beta-thalassemia and myelodysplastic syndrome. The former silences the LPA gene, lowering lipoprotein(a) levels and reducing the risk of heart diseases and strokes….

July 22, 2022 - 7 minutesmins - By Farhan Mitha

Podcast 2 Feb 2024

BioSenic showcasing knee osteoarthritis treatment

…interesting, powerful drug that could be really revolutionary,” Nicco said. “I think that this compound could be incredibly useful for patients with really difficult diseases, autoimmune diseases, and we should…

February 2, 2024 - 7 minutesmins - By Jim Cornall

News and Trends 22 Sep 2022

Research identifies new treatment target for CNS injury and neurological disease

…research started out exploring DNA damage pathways activated following nerve injury. However, the same molecular factors feature in pathways are seen in neurodegenerative diseases, and a full understanding of these…

September 22, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 18 Oct 2022

EditForce creates U-to-C RNA-editing technology

…or RNA sequence cause a variety of diseases. Treatment of these diseases requires single base-editing technology of repairing genomic or RNA mutations to bring the sequences back on the normal…

October 18, 2022 - 2 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Anti-Aging Treatments at Forefront of Astellas’ €80M UK Acquisition

Why are there only 20 cell and gene therapies in Europe?

Swiss Biotech Launches Amidst Hot Streak for Rare Autoimmune Disease

Providence Therapeutics’ mRNA rabies vaccine hits milestone

Five biotech companies making a name for themselves in Vancouver

Immune memory research could lead to next generation of epigenetic drugs

What’s the Vatican doing with Biotech? Awarding Billionaire Doctors for Cancer & Stem Cell Research

Small but mighty: The role of small-molecule drugs in disease treatment

The coming of age story of RNAi technology

BioSenic showcasing knee osteoarthritis treatment

Research identifies new treatment target for CNS injury and neurological disease

EditForce creates U-to-C RNA-editing technology

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!